Cargando…

Comparison of preferences of healthcare professionals and MS patients for attributes of disease‐modifying drugs: A best‐worst scaling

BACKGROUND: The choice between disease‐modifying drugs (DMDs) for the treatment of multiple sclerosis (MS) becomes more often a shared decision between the patient and the neurologist and MS nurse. This study aimed to assess which DMD attributes are most important for the healthcare professionals in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kremer, Ingrid E. H., Evers, Silvia M. A. A., Jongen, Peter J., Hiligsmann, Mickaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750752/
https://www.ncbi.nlm.nih.gov/pubmed/28734004
http://dx.doi.org/10.1111/hex.12599